1. A citrullinated antigenic vaccine in treatment of autoimmune arthritis.
- Author
-
Jin, Xu, Dong, Tianya, Wang, Qian, Xie, Yang, Fang, Xiangyu, Wei, Chaonan, Liu, Shuyan, Zheng, Xi, Wang, Ping, Zhu, Danxue, Cao, Lulu, Dong, Suwei, Fang, Kechi, Zhong, Chao, Wang, Jing, Hu, Fanlei, and Li, Zhanguo
- Subjects
- *
B cell receptors , *IMMUNOLOGICAL tolerance , *T helper cells , *COLLAGEN-induced arthritis , *RHEUMATOID arthritis - Abstract
[Display omitted] Rheumatoid arthritis (RA) is an inflammatory autoimmune disease triggered by antigenic peptides with environmental and genetic risk factors. It has been shown that antigen-specific targeting could be a promising therapeutical strategy for RA by restoring immune tolerance to self-antigens without compromising normal immunity. Citrullination of antigens enhances antigenic properties and induces autoimmune responses. Here, we showed that citrullinated antigenic (citAg) vaccine ameliorated collagen-induced arthritis with decreased T-helper 1 (Th1) and Th17 cells, downregulated proinflammatory cytokines including interlukin-6 and tumor necrosis factor-α, and inhibited antigen recall responses. B cell receptor sequencing further revealed that citAg vaccine could dampen the dysregulated V(D)J recombination, restoring the immune repertoire. Taken together, the results demonstrated that citAg vaccine might have a therapeutic effect on RA. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF